Already recovering from weakness suffered early this year, Acadia Pharmaceuticals (NASDAQ: ACAD) shares were outright ...

Currax has rolled out a new AI tool, SuperAgents, which it says helps sales reps save time and improve conversations in their ...

In the past six months, there have been 33 biotech acquisitions valued at $1 billion or more, capped by AbbVie’s acquisition ...

Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (the “Company ” or “Helus Pharma ”), a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists ...

Universe Pharmaceuticals agreed to acquire Best Praise International Limited in an all-stock deal valued at $10.8 million. Universe will pay for the acquisition with about 4.8 million shares of its ...

From gene-editing breakthroughs to blockbuster cystic fibrosis drugs, these two industry leaders present sharply contrasting ...

Crinetics Pharmaceuticals stock is a 'Buy' rating due to EU approval and strong initial U.S. uptake of Palsonify for ...

Driven by personal losses, major unmet needs and a desire to diversify from the crowded oncology market, Fosun Pharma is ...

Healthcare marketers heading to the Croisette can expect fewer theoretical promises around AI, more scrutiny of what actually ...

Universe Pharmaceuticals (UPC) to buy Best Praise for $10.75M in shares, adding 5 China patents to boost elderly healthcare R&D.

Investors looking for large returns without making a sizable initial commitment are still drawn to low-priced companies.